Inhibitory Effects of Dendrobium Alkaloids on Memory Impairment Induced by Lipopolysaccharide in Rats

Abstract

Dendrobium alkaloids (DNLA), extracted from Dendrobium nobile Lindl. whose botanical name is Dendrobium moniliforme, Orchidaceae family, were studied for their effect on lipopolysaccharide (LPS)-induced memory impairment in rats. SD rats were pretreated with DNLA (40, 80, 160 mg/kg/d for 7 d), followed by LPS (50 µg) injection into the right lateral ventricle to produce memory impairment. DNLA treatment continued for another 13 days. The spatial behavior was tested by the Morris water maze; the level of tumor necrosis factor receptor 1 (TNFR1) mRNA was detected by real time RT‐PCR, and the protein level of TNFR1, nuclear factor kappa-B (NF-κB) and phosphorylated p38 mitogen-activated protein kinases (p-p38 MAPK) by Western blotting. The results showed that DNLA significantly improved the neurobehavioral performance and prevented LPS-induced elevation in TNFR1 mRNA and protein levels. LPS-induced activation of p38 MAPK and NF-κB pathway was also suppressed. In conclusion, DNLA is effective in protecting against LPS-induced brain impairment, and this effect is due, at least in part, to prevent overexpression of TNFR1 via inhibition of p-p38 MAPK and the downstream NF-κB signal pathway.

Key words

Dendrobium alkaloids - Dendrobium nobile Lindl. - Orchidaceae - lipopolysaccharide - Morris water maze - TNFR1 - nuclear factor kappa‐B - p‐p38 MAPK

References

• 1 Selkoe D J. Alzheimer's disease: genes, proteins, and therapy.  Physiol Rev. 2001;  81 741-766
• 2 Pratico D, Trojanowski J Q. Inflammatory hypotheses: novel mechanisms of Alzheimer's neurodegeneration and new therapeutic targets?.  Neurobiol Aging. 2000;  21 441-445
• 3 Combs C K, Karlo J C, Kao S C, Landreth G E. beta-Amyloid stimulation of microglia and monocytes results in TNF alpha-dependent expression of inducible nitric oxide synthase and neuronal apoptosis.  J Neurosci. 2001;  21 1179-1188
• 4 Miklossy J, Kis A, Radenovic A, Miller L, Forro L, Martins R, Reiss K, Darbinian N, Darekar P, Mihaly L, Khalili K. Beta-amyloid deposition and Alzheimer's type changes induced by Borrelia spirochetes.  Neurobiol Aging. 2006;  27 228-236
• 5 Lee J W, Lee Y K, Yuk D Y, Choi D Y, Ban S B, Oh K W, Hong J T. Neuro-inflammation induced by lipopolysaccharide causes cognitive impairment through enhancement of beta amyloid generation.  J Neuroinflammation. 2008;  5 37
• 6 Akiyama H, Barger S, Barnum S, Bradt B, Bauer J, Cole G M, Cooper N R, Eikelenboom P, Emmerling M, Fiebich B L, Finch C E, Frautschy S, Griffin W S, Hampel H, Hull M, Landreth G, Lue L, Mrak R, Mackenzie I R, McGeer P L, O'Banion M K, Pachter J, Pasinetti G, Plata-Salaman C, Rogers J, Rydel R, Shen Y, Streit W, Strohmeyer R, Tooyoma I, Van Muiswinkel F L, Veerhuis R, Walker D, Webster S, Wegrzyniak B, Wenk G, Wyss-Coray T. Inflammation and Alzheimer's disease.  Neurobiol Aging. 2000;  21 383-421
• 7 Sasaki A, Shoji M, Harigaya Y, Kawarabayashi T, Ikeda M, Naito M, Matsubara E, Abe K, Nakazato Y. Amyloid cored plaques in Tg2576 transgenic mice are characterized by giant plaques, slightly activated microglia, and the lack of paired helical filament-typed, dystrophic neurites.  Virchows Arch. 2002;  441 358-367
• 8 Lim G P, Yang F, Chu T, Chen P, Beech W, Teter B, Tran T, Ubeda O, Ashe K H, Frautschy S A, Cole G M. Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer's disease.  J Neurosci. 2000;  20 5709-5714
• 9 McGeer E G, McGeer P L. Inflammatory processes in Alzheimer's disease.  Prog Neuropsychopharmacol Biol Psychiatry. 2003;  27 741-749
• 10 Tabet N, Feldmand H. Ibuprofen for Alzheimer's disease.  Cochrane Database Syst Rev. 2003;  (2) CD004031
• 11 Stichtenoth D O, Frölich J C. COX-2 and the kidneys.  Curr Pharm Des. 2000;  6 1737-1753
• 12 Graupera M, García-Pagán J C, Abraldes J G, Peralta C, Bragulat M, Corominola H, Bosch J, Rodés J. Cyclooxygenase-derived products modulate the increased intrahepatic resistance of cirrhotic rat livers.  Hepatology. 2003;  37 172-181
• 13 Zhang G N, Zhong L Y, Bligh S W A, Guo Y L, Zhang C F, Zhang M, Wang Z T, Xu L S. Bi-bicyclic and bi-tricyclic compounds from Dendrobium thyrsiflorum.  Phytochemistry. 2005;  66 1113-1120
• 14 Wang Q, Gong Q H, Wu Q, Shi J S. Neuroprotective effects of Dendrobium alkaloids on rat cortical neurons injured by oxygen-glucose deprivation and reperfusion.  Phytomedicine. 2010;  17 108-115
• 15 Chen J W, Ma H, Huang X N, Gong Q H, Wu Q, Shi J S. Improvement of Dendrobium nobile Lindl. alkaloids on cognitive deficit in rats induced by lipopolysaccharides.  Chin J Pharmacol Toxicol. 2008;  22 406-411
• 16 Morris R. Developments of a water-maze procedure for studying spatial learning in the rat.  J Neurosci Methods. 1984;  11 47-60
• 17 Gong Q H, Wu Q, Huang X N, Sun A S, Shi J S. Protective effects of Ginkgo biloba leaf extract on aluminum-induced brain dysfunction in rats.  Life Sci. 2005;  77 140-148
• 18 Min S S, Quan H Y, Ma J, Han J S, Jeon B H, Seol G H. Chronic brain inflammation impairs two forms of long-term potentiation in the rat hippocampal CA1 area.  Neurosci Lett. 2009;  456 20-24
• 19 Fan L W, Pang Y, Lin S, Tien L T, Ma T, Rhodes P G, Cai Z. Minocycline reduces lipopolysaccharide-induced neurological dysfunction and brain injury in the neonatal rat.  J Neurosci Res. 2005;  82 71-82
• 20 Bao X M. Stereotaxic atlas of rat's brain [M]. Beijing; People's Medical Publishing House 1991: 46-54
• 21 Zilka N, Ferencik M, Hulin I. Neuroinflammation in Alzheimer's disease: protector or promoter?.  Bratisl Lek Listy. 2006;  107 374-383
• 22 Maccioni R B, Rojo L E, Fernández J A, Kuljis R O. The role of neuroimmunomodulation in Alzheimer's disease.  Ann NY Acad Sci. 2009;  1153 240-246
• 23 Rogers J, Mastroeni D, Leonard B, Joyce J, Grover A. Neuroinflammation in Alzheimer's disease and Parkinson's disease: are microglia pathogenic in either disorder?.  Int Rev Neurobiol. 2007;  82 235-246
• 24 Townsend K P, Praticò D. Novel therapeutic opportunities for Alzheimer's disease: focus on nonsteroidal anti-inflammatory drugs.  FASEB J. 2005;  19 1592-1601
• 25 Tegeder I, Pfeilschifter J, Geisslinger G. Cyclooxygenase-independent actions of cyclooxygenase inhibitors.  FASEB J. 2001;  15 2057-2072
• 26 Glibetic M, Samlalsingh-Parker J, Raykova V, Ofenstein J, Aranda J V. Group B streptococci and inducible nitric oxide synthase: modulation by nuclear factor kappa B and ibuprofen.  Semin Perinatol. 2001;  25 65-69
• 27 Richardson R L, Kim E M, Gardiner T, O'Hare E. Chronic intracerebroventricular infusion of lipopolysaccharide: effects of ibuprofen treatment and behavioural and histopathological correlates.  Behav Pharmacol. 2005;  16 531-541
• 28 Inukai T, Uchida K, Nakajima H, Yayama T, Kobayashi S, Mwaka E S, Guerrero A R, Baba H. Tumor necrosis factor-alpha and its receptors contribute to apoptosis of oligodendrocytes in the spinal cord of spinal hyperostotic mouse (twy/twy) sustaining chronic mechanical compression.  Spine (Phila Pa 1976). 2009;  34 2848-2857
• 29 Morrison R S, Kinoshita Y, Johnson M D, Ghatan S, Ho J T, Garden G. Neuronal survival and cell death signaling pathways.  Adv Exp Med Biol. 2002;  513 41-86
• 30 Kaltschmidt B, Kaltschmidt C. NF-kB in the nervous system.  Cold Spring Harb Perspect Biol. 2009;  , , advance online publication 1 September 2009
  DOI: 10.1101/cshperspect.a001271
• 31 Rincón M, Enslen H, Raingeaud J, Recht M, Zapton T, Su M S, Penix L A, Davis R J, Flavell R A. Interferon-gamma expression by Th1 effector T cells mediated by the p38 MAP kinase signaling pathway.  EMBO J. 1998;  7 2817-2829
• 32 Zhu X, Rottkamp C A, Boux H, Takeda A, Perry G, Smith M A. Activation of p38 kinase links tau phosohorylation, oxidative stress, and cell cycle-related events in Alzheimer disease.  J Neuropathol Exp Neurol. 2000;  59 880-888